01-07-2019 | Cetuximab | Letter to Editor
Cisplatin-based chemoradiotherapy trumps cetuximab-based bioradiotherapy in p16/HPV-positive oropharyngeal cancers
Published in: European Archives of Oto-Rhino-Laryngology | Issue 7/2019
Login to get access